Terrence Blaschke
Overview
Explore the profile of Terrence Blaschke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
2972
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Browne S, Umlauf A, Tucker A, Low J, Moser K, Gonzalez Garcia J, et al.
PLoS Med
. 2019 Oct;
16(10):e1002891.
PMID: 31584944
Background: Excellent adherence to tuberculosis (TB) treatment is critical to cure TB and avoid the emergence of resistance. Wirelessly observed therapy (WOT) is a novel patient self-management system consisting of...
2.
Mallayasamy S, Chaturvedula A, Blaschke T, Fossler M
CPT Pharmacometrics Syst Pharmacol
. 2018 Oct;
7(12):818-828.
PMID: 30291680
The objective of our study was to evaluate the effect of adherence patterns on the sample size and power of a clinical trial. Simulations from a population pharmacokinetic/pharmacodynamic (PK/PD) model...
3.
Liu X, Blaschke T, Thomas B, de Geest S, Jiang S, Gao Y, et al.
Int J Environ Res Public Health
. 2017 Sep;
14(10).
PMID: 28946683
Poor initiation and implementation and premature discontinuation of anti-tuberculous therapy, all forms of nonadherence, are major reasons for treatment failure, the development of drug-resistant tuberculosis, and transmission to other non-infected...
4.
Osterberg L, Blaschke T
N Engl J Med
. 2005 Aug;
353(5):487-97.
PMID: 16079372
No abstract available.
5.
Adelman C, Blaschke T, Norris J
Lancet
. 2004 Sep;
364(9439):1037-8.
PMID: 15380960
No abstract available.
6.
Fichtenbaum C, Gerber J, Rosenkranz S, Segal Y, Aberg J, Blaschke T, et al.
AIDS
. 2002 Mar;
16(4):569-77.
PMID: 11873000
Objective: Lipid lowering therapy is used increasingly in persons with HIV infection in the absence of safety data or information on drug interactions with antiretroviral agents. The primary objectives of...